IMMUNOHISTOCHEMISTRY EVALUATION ON PRE-TREATMENT TUMOR TISSUE PREDICTS TREATMENT RESPONSE TO MN-166 (IBUDILAST) AND TEMOZOLOMIDE COMBINATION THERAPY IN GLIOBLASTOMA PATIENTS

被引：0
|
作者：
Lathia, Justin [1 ]
Lauko, Adam [2 ]
Matsuda, Kazuko [3 ]
Makhay, Malath [3 ]
Nayak, Lakshmi [4 ]
Chukwueke, Ugonma [4 ]
Lee, Eudocia [4 ]
Reardon, David [5 ]
Beroukhim, Rameen [5 ]
Batchelor, Tracy [4 ]
Aquilanti, Elisa [4 ]
Wen, Patrick [6 ]
机构：
[1] Cleveland Clin, Dept Cardiovasc & Metab Sci, Lerner Res Inst, Cleveland, OH USA
[2] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA
[3] MediciNova Inc, La Jolla, CA USA
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Dana Farber Canc Inst, Ctr Neuro Oncol, Boston, MA USA
[6] Brigham & Womens Canc Ctr, Dana Farber, Boston, MA USA
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CTIM-36
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase 1b/2a study evaluating the combination of MN-166 (ibudilast) and temozolomide in patients with newly diagnosed and recurrent glioblastoma (GBM).
    Youssef, Gilbert
    Lathia, Justin
    Lee, Eudocia Quant
    Chukwueke, Ugonma Nnenna
    Lauko, Adam
    Batchelor, Tracy
    Aquilanti, Elisa
    Nayak, Lakshmi
    Myers, Alexa
    Russ, Alyssa
    Westergaard, Catharina C.
    Alban, Tyler
    Jarmula, Jakub
    Lee, Juyeun
    Vogelbaum, Michael A.
    Matsuda, Kazuko
    Reardon, David A.
    Wen, Patrick Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Contrast enhancing pattern on pre-treatment MRI predicts response to anti-angiogenic treatment in recurrent glioblastoma: comparison of bevacizumab and temozolomide treatment
    Hye Hyeon Moon
    Ji Eun Park
    Young-Hoon Kim
    Jeong Hoon Kim
    Ho Sung Kim
    [J]. Journal of Neuro-Oncology, 2022, 157 : 405 - 415
  • [3] Contrast enhancing pattern on pre-treatment MRI predicts response to anti-angiogenic treatment in recurrent glioblastoma: comparison of bevacizumab and temozolomide treatment
    Moon, Hye Hyeon
    Park, Ji Eun
    Kim, Young-Hoon
    Kim, Jeong Hoon
    Kim, Ho Sung
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2022, 157 (03) : 405 - 415
  • [4] Pre-treatment amygdala volume predicts electroconvulsive therapy response
    ten Doesschate, Freek
    van Eijndhoven, Philip
    Tendolkar, Indira
    van Wingen, Guido A.
    van Waarde, Jeroen A.
    [J]. FRONTIERS IN PSYCHIATRY, 2014, 5
  • [5] Radiomics of the lesion habitat on pre-treatment MRI predicts response to chemo-radiation therapy in Glioblastoma
    Verma, Ruchika
    Correa, Ramon
    Hill, Virginia
    Beig, Niha
    Mahammedi, Abdelkader
    Madabhushi, Anant
    Tiwari, Pallavi
    [J]. MEDICAL IMAGING 2019: COMPUTER-AIDED DIAGNOSIS, 2019, 10950
  • [6] Analysis of tumor texture on a pre-treatment CT scan predicts treatment outcome in NSCLC patients
    Velazquez, E. Rios
    Aerts, J. H.
    Dehing-Oberije, C.
    Petit, S.
    Eikelder, H.
    De-Ruysscher, D.
    Riel, A. N.
    Lambin, P.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 522 - 523
  • [7] THE PRE-TREATMENT GUT MICROBIOME PREDICTS EARLY RESPONSE TO RHEUMATOID ARTHRITIS THERAPY
    Isaac, Sandrine
    Artacho, Alejandro
    Nayak, Renuka
    Flor, Alejandra
    Abramson, Steven
    Rosenthal, Pamela
    Puchades, Leonor
    Patterson, Andrew
    Pineda-Lucena, Antonio
    Turnbaugh, Peter
    Ubeda, Carles
    Scher, Jose
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 133 - 134
  • [8] RADIOMIC PROFILING MAPS AREAS OF PATHOLOGICALLY CONFIRMED TUMOR AND PREDICTS OVERALL SURVIVAL IN PRE-TREATMENT GLIOBLASTOMA
    McGarry, Sean
    Hurrell, Sarah
    Kaczmarowski, Amy
    Cochran, Elizabeth
    Connelly, Jennifer M.
    Bovi, Joseph
    Rand, Scott
    Schmainda, Kathleen M.
    LaViolette, Peter S.
    [J]. NEURO-ONCOLOGY, 2016, 18 : 129 - 129
  • [9] Lipid profiling of pre-treatment liver biopsy tissue predicts sustained virological response in patients with chronic hepatitis C
    Cobbold, Jeremy F. L.
    Cox, I. Jane
    Brown, Ashley S.
    Williams, Horace R. T.
    Goldin, Robert D.
    Thomas, Howard C.
    Thursz, Mark R.
    Taylor-Robinson, Simon D.
    [J]. HEPATOLOGY RESEARCH, 2012, 42 (07) : 714 - 720
  • [10] PRE-TREATMENT PLATELET COUNT AS A PROGNOSTIC MARKER IN PATIENTS WITH GLIOBLASTOMA (GBM) TREATED WITH RADIOTHERAPY AND CONCURRENT AND ADJUVANT TEMOZOLOMIDE (RCAT)
    Michalarea, V.
    Williams, M. H.
    Liu, Z. W.
    Hargreaves, S.
    Woolf, D.
    Wilson, E.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 331 - 331
12345